Xeris Biopharma Holdings Inc banner

Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 5.965 USD 0.42% Market Closed
Market Cap: $989.7m

Profitability Summary

Xeris Biopharma Holdings Inc's profitability score is 56/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

56/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

56/100
Profitability
Score
56/100
Profitability
Score

Margins

Earnings Waterfall
Xeris Biopharma Holdings Inc

Margins Comparison
Xeris Biopharma Holdings Inc Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
US
Xeris Biopharma Holdings Inc
NASDAQ:XERS
983.2m USD
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
952.4B USD
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.2B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282.2B CHF
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
242.7B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
232.5B GBP
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
298.8B USD
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.8B USD
Loading...
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Xeris Biopharma Holdings Inc Competitors

Country Company Market Cap ROE ROA ROCE ROIC
US
Xeris Biopharma Holdings Inc
NASDAQ:XERS
983.2m USD
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
952.4B USD
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
592.2B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
282.2B CHF
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
242.7B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
232.5B GBP
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
298.8B USD
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
151.6B USD
Loading...
Loading...
Loading...
Loading...
US
Bristol-Myers Squibb Co
NYSE:BMY
125.8B USD
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Xeris Biopharma Holdings Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett